The stability of TβRII mRNA in Gr-1+CD11b+ cells from tumor-bearing mice was much greater compared to those from healthy control mice (Fig. 1b) when the myeloid cells were treated with Actinomycin D, a polypeptide antibiotic that interferes with new mRNA synthesis. This evidence concerns the gene TGFBR2 and neoplasm.